Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations.

Source:http://linkedlifedata.com/resource/pubmed/id/12132671

Download in:

View as

General Info

PMID
12132671